4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-007547
Chief Business Development Off sold 6,770 shares at an average $55.65 ($376,720)
- Chief Business Development Off acquired 6,770 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BENZENO SHARON · Chief Business Development Off
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 1 in the form | +2,604 | $6.55 | $17,056 | 2,604 | D |
| 2021-02-01 | Exercise or conversion : show line 2 in the form | +2,604 | $6.55 | $17,056 | 5,208 | D |
| 2021-02-01 | Exercise or conversion : show line 3 in the form | +1,562 | $7.27 | $11,356 | 6,770 | D |
| 2021-02-01 | Sale : show line 4 in the form | −6,470 | $55.61 | $359,797 | 300 | D |
| 2021-02-01 | Sale : show line 5 in the form | −300 | $56.41 | $16,923 | 0 | D |
| Open-market sales · 6,770 sh · avg $55.65 · $376,720 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −2,604 | 23,438 | D |
| 2021-02-01 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −2,604 | 52,084 | D |
| 2021-02-01 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −1,562 | 35,938 | D |
Loading xslF345X03/doc4.xml…